- Home
- AVDX vs BHVN Comparison
AVDX vs BHVN Comparison
Compare AVDX & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDX
- BHVN
- Stock Information
- Founded
- AVDX 2000
- BHVN 2013
- Country
- AVDX United States
- BHVN United States
- Employees
- AVDX N/A
- BHVN N/A
- Industry
- AVDX EDP Services
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- AVDX Technology
- BHVN Health Care
- Exchange
- AVDX Nasdaq
- BHVN Nasdaq
- Market Cap
- AVDX 2.0B
- BHVN 1.9B
- IPO Year
- AVDX 2021
- BHVN 2017
- Fundamental
- Price
- AVDX $9.77
- BHVN $14.45
- Analyst Decision
- AVDX Hold
- BHVN Strong Buy
- Analyst Count
- AVDX 15
- BHVN 14
- Target Price
- AVDX $10.04
- BHVN $58.85
- AVG Volume (30 Days)
- AVDX 3.5M
- BHVN 2.1M
- Earning Date
- AVDX 07-30-2025
- BHVN 08-07-2025
- Dividend Yield
- AVDX N/A
- BHVN N/A
- EPS Growth
- AVDX N/A
- BHVN N/A
- EPS
- AVDX 0.01
- BHVN N/A
- Revenue
- AVDX $441,284,000.00
- BHVN N/A
- Revenue This Year
- AVDX $5.56
- BHVN N/A
- Revenue Next Year
- AVDX $10.01
- BHVN $59.97
- P/E Ratio
- AVDX $1,094.40
- BHVN N/A
- Revenue Growth
- AVDX 10.46
- BHVN N/A
- 52 Week Low
- AVDX $6.61
- BHVN $13.87
- 52 Week High
- AVDX $12.93
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- AVDX 67.77
- BHVN 33.35
- Support Level
- AVDX $9.75
- BHVN $14.95
- Resistance Level
- AVDX $9.82
- BHVN $17.73
- Average True Range (ATR)
- AVDX 0.03
- BHVN 0.87
- MACD
- AVDX -0.05
- BHVN 0.04
- Stochastic Oscillator
- AVDX 33.33
- BHVN 15.03
About AVDX AvidXchange Holdings Inc.
AvidXchange Holdings Inc is a provider of AP automation software and payment solutions for middle-market businesses and their suppliers. It generates the majority of its sales from Payment revenue followed by Software revenue and Services revenue. The company generates revenue in the United States.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.